US FDA explains informed consent exemption during emergency trials
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration has issued final guidance to help institutional review boards, clinical investigators and sponsors oversee clinical trials of medical devices, drugs and biologics in emergency settings, when an exception from the informed consent requirements is requested1,2.